The Tata Memorial Hospital is situated in Parel, Mumbai, in India. Also popularly known as TMH. It is a specialist cancer treatment and research centre, closely associated with the Advanced Centre for Treatment, Research and Education in Cancer.

During the past decade, Tata Memorial Hospital conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 29 clinical trials were completed, i.e. on average, 31.5% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 13 clinical trials were completed. i.e. 34.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tata Memorial Hospital" #1 sponsor was "Tata Memorial Hospital" with 54 trials, followed by "Tata Memorial Centre" with 22 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Pfizer" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tata Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Tata Memorial Hospital" with 6 trials as a collaborator, "Ministry of Science and Technology, India" with 4 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Tata Memorial Hospital" are "Breast Cancer" (16 trials), "Cervical Cancer" (8 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Cancer of Cervix" (5 trials) and "Breast Neoplasms" (4 trials). Many other conditions were trialed in "Tata Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Tata Memorial Hospital" are "Drug" (101 trials), "Other" (34 trials), "Radiation" (34 trials), "Procedure" (18 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cisplatin" (4 trials), "Letrozole" (4 trials), "Paclitaxel" (4 trials) and "Radiotherapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Tata Memorial Hospital" are 126 trials for "All" genders, 43 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Tata Memorial Hospital". 4 are not yet recruiting, 40 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Tata Memorial Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Tata Memorial Hospital, 8 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 30 trials that are defined as “Not Applicable".

Tata Memorial Hospital has several departments that took part in Clinical trials: "Department of Preventive Oncology, Tata Memorial Hospital" - 2 trials